{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:39Z","timestamp":1786120419525,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V028553\/1"],"award-info":[{"award-number":["MR\/V028553\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioadv.2026.214984","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:41:34Z","timestamp":1780332094000},"page":"214984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the impact of dynamic fluid flow on an advanced model of pancreatic cancer: Towards desmoplasia disruption and chemosensitivity promotion"],"prefix":"10.1016","volume":"188","author":[{"given":"Priyanka","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksiy V.","family":"Klymenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Bakkalci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umber","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant M.","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"P\u00e9rez-Mancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini G.","family":"Velliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214984_bb0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1349-7006.2012.02297.x","article-title":"Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer","volume":"103","author":"Onishi","year":"2012","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214984_bb0015","first-page":"1811","article-title":"Metformin synergizes with rapamycin to inhibit the growth of pancreatic cancer in vitro and in vivo","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214984_bb0020","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1002\/jcp.27297","article-title":"Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: a preliminary in vitro study","volume":"234","author":"Serri","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1245\/s10434-017-6239-y","article-title":"Effect of plasma-activated lactated ringer\u2019s solution on pancreatic cancer cells in vitro and in vivo","volume":"25","author":"Sato","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214984_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067330","article-title":"Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer","volume":"8","author":"Courtin","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bioadv.2026.214984_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2019.05.037","article-title":"Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel\/gemcitabine chemotherapy response in preclinical models of pancreatic cancer","volume":"459","author":"Awasthi","year":"2019","journal-title":"Cancer Lett."},{"issue":"47","key":"10.1016\/j.bioadv.2026.214984_bb0040","doi-asserted-by":"crossref","first-page":"28434","DOI":"10.18632\/oncotarget.25421","article-title":"Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo","volume":"9","author":"Shinoda","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0045","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/s41598-020-62416-x","article-title":"Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes","volume":"10","author":"Pausch","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214984_bb0050","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1021\/acs.nanolett.9b00859","article-title":"Impacting pancreatic cancer therapy in heterotypic in vitro organoids and in vivo tumors with specificity-tuned, NIR-activable photoimmunonanoconjugates: towards conquering desmoplasia?","volume":"19","author":"Obaid","year":"2019","journal-title":"Nano Lett."},{"issue":"13","key":"10.1016\/j.bioadv.2026.214984_bb0055","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/cancers13133169","article-title":"The antitumor activity of sodium selenite alone and in combination with gemcitabine in pancreatic cancer: an in vitro and in vivo study","volume":"13","author":"Doello","year":"2021","journal-title":"Cancers"},{"issue":"247","key":"10.1016\/j.bioadv.2026.214984_bb0060","first-page":"2","article-title":"Three-dimensional (3D) cell cultures in cell-based assays for in-vitro evaluation of anticancer drugs","volume":"6","author":"Adcock","year":"2015","journal-title":"J Anal Bioanal Tech"},{"key":"10.1016\/j.bioadv.2026.214984_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cobme.2018.03.004","article-title":"Biomechanical forces in tissue engineered tumor models","volume":"6","author":"Chim","year":"2018","journal-title":"Current Opinion in Biomedical Engineering"},{"key":"10.1016\/j.bioadv.2026.214984_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msec.2014.11.027","article-title":"Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy","volume":"47","author":"Jaidev","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214984_bb0075","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.drudis.2017.01.012","article-title":"Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer","volume":"22","author":"Totti","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2026.214984_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.copbio.2015.05.005","article-title":"Use of DNA transposons for functional genetic screens in mouse models of cancer","volume":"35","author":"Bermejo-Rodr\u00edguez","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"issue":"7","key":"10.1016\/j.bioadv.2026.214984_bb0085","doi-asserted-by":"crossref","first-page":"dmm034793","DOI":"10.1242\/dmm.034793","article-title":"Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy","volume":"11","author":"Erstad","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bioadv.2026.214984_bb0090","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/2159-8290.CD-18-1409","article-title":"Oncogenic Kras induces Nix-mediated mitophagy to promote pancreatic cancer","volume":"9","author":"Humpton","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioadv.2026.214984_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biomaterials.2018.05.020","article-title":"High throughput scaffold-based 3D micro-tumor array for efficient drug screening and chemosensitivity testing","volume":"198","author":"Yan","year":"2019","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.bioadv.2026.214984_bb0100","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-16-1201","article-title":"Chemoresistance in pancreatic cancer is driven by stroma-derived insulin-like growth factors","volume":"76","author":"Ireland","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214984_bb0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2012.03.002","article-title":"What we have learned about pancreatic cancer from mouse models","volume":"142","author":"P\u00e9rez-Mancera","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bioadv.2026.214984_bb0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10616-022-00553-z","article-title":"Scaffold-based three-dimensional cell model of pancreatic cancer is more suitable than scaffold-free three-dimensional cell model of pancreatic cancer for drug discovery","volume":"74","author":"Xie","year":"2022","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bioadv.2026.214984_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101374","article-title":"Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells","volume":"55","author":"Affram","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-95","article-title":"3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing","volume":"13","author":"Longati","year":"2013","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214984_bb0125","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1021\/bm4004496","article-title":"Effect of 3D matrix compositions on the efficacy of EGFR inhibition in pancreatic ductal adenocarcinoma cells","volume":"14","author":"Ki","year":"2013","journal-title":"Biomacromolecules"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214984_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101107","article-title":"3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma","volume":"14","author":"Liu","year":"2021","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-12-15","article-title":"Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine\/CHK1 inhibitor combination in pancreatic cancer","volume":"12","author":"Dufau","year":"2012","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214984_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084289","article-title":"Tissue-engineering the fibrous pancreatic tumour stroma capsule in 3D tumouroids to demonstrate paclitaxel response","volume":"22","author":"Pape","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"71","key":"10.1016\/j.bioadv.2026.214984_bb0145","doi-asserted-by":"crossref","first-page":"41649","DOI":"10.1039\/C9RA09123H","article-title":"Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model","volume":"9","author":"Gupta","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2026.214984_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00290","article-title":"A novel scaffold-based hybrid multicellular model for pancreatic ductal adenocarcinoma\u2014toward a better mimicry of the in vivo tumor microenvironment","volume":"8","author":"Gupta","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"37","key":"10.1016\/j.bioadv.2026.214984_bb0155","doi-asserted-by":"crossref","first-page":"20928","DOI":"10.1039\/C8RA02633E","article-title":"A 3D bioinspired highly porous polymeric scaffolding system for in vitro simulation of pancreatic ductal adenocarcinoma","volume":"8","author":"Totti","year":"2018","journal-title":"RSC Adv."},{"issue":"23","key":"10.1016\/j.bioadv.2026.214984_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236080","article-title":"On the evaluation of a novel hypoxic 3D pancreatic cancer model as a tool for radiotherapy treatment screening","volume":"13","author":"Wishart","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1120","key":"10.1016\/j.bioadv.2026.214984_bb0165","doi-asserted-by":"crossref","first-page":"20201397","DOI":"10.1259\/bjr.20201397","article-title":"3d tissue models as tools for radiotherapy screening for pancreatic cancer","volume":"94","author":"Wishart","year":"2021","journal-title":"Br. J. Radiol."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214984_bb0170","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.1021\/acsami.5c02296","article-title":"Mapping tumor\u2013stroma\u2013ECM interactions in spatially advanced 3D models of pancreatic cancer","volume":"17","author":"Kataki","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0175","doi-asserted-by":"crossref","DOI":"10.4161\/21592527.2014.955386","article-title":"Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models","volume":"4","author":"Ricci","year":"2014","journal-title":"Biomatter"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.slasd.2022.03.002","article-title":"Lead identification using 3D models of pancreatic cancer","volume":"27","author":"Fernandez-Vega","year":"2022","journal-title":"Slas Discovery"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214984_bb0185","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/cancers11050638","article-title":"Role of c-MET inhibitors in overcoming drug resistance in spheroid models of primary human pancreatic cancer and stellate cells","volume":"11","author":"Firuzi","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214984_bb0190","first-page":"1806","article-title":"Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma","volume":"13","author":"Hahn","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bioadv.2026.214984_bb0195","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.actbio.2018.08.008","article-title":"Multicellular spheroid based on a triple co-culture: a novel 3D model to mimic pancreatic tumor complexity","volume":"78","author":"Lazzari","year":"2018","journal-title":"Acta Biomater."},{"issue":"13","key":"10.1016\/j.bioadv.2026.214984_bb0200","doi-asserted-by":"crossref","first-page":"2102574","DOI":"10.1002\/adhm.202102574","article-title":"Programmable living units for emulating pancreatic tumor-stroma interplay","volume":"11","author":"Monteiro","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioadv.2026.214984_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119421","article-title":"Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer","volume":"222","author":"Broekgaarden","year":"2019","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25921-9","article-title":"Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology","volume":"12","author":"Osuna de la Pe\u00f1a","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.214984_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2021.704584","article-title":"3D collagen-nanocellulose matrices model the tumour microenvironment of pancreatic cancer","volume":"3","author":"Curvello","year":"2021","journal-title":"Front. Digital Health"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7150\/ntno.38092","article-title":"FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor","volume":"4","author":"Mardhian","year":"2020","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.bioadv.2026.214984_bb0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biomaterials.2016.08.041","article-title":"Generation of an in vitro 3D PDAC stroma rich spheroid model","volume":"108","author":"Ware","year":"2016","journal-title":"Biomaterials"},{"issue":"27","key":"10.1016\/j.bioadv.2026.214984_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm9071","article-title":"Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy","volume":"10","author":"Hughes","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0235","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41563-021-01085-1","article-title":"A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids","volume":"21","author":"Below","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bioadv.2026.214984_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122631","article-title":"A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism","volume":"310","author":"Li","year":"2024","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214984_bb0245","doi-asserted-by":"crossref","first-page":"2300580","DOI":"10.1002\/adbi.202300580","article-title":"Chemotherapy assessment in advanced multicellular 3D models of pancreatic cancer: unravelling the importance of spatiotemporal mimicry of the tumor microenvironment","volume":"8","author":"Gupta","year":"2024","journal-title":"Advanced Biology"},{"key":"10.1016\/j.bioadv.2026.214984_bb0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.addr.2014.07.012","article-title":"3D tissue-engineered model of Ewing\u2019s sarcoma","volume":"79","author":"Lamhamedi-Cherradi","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tibtech.2009.12.001","article-title":"Can tissue engineering concepts advance tumor biology research?","volume":"28","author":"Hutmacher","year":"2010","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0260","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41598-017-01256-8","article-title":"A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts","volume":"7","author":"Beer","year":"2017","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.bioadv.2026.214984_bb0265","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.3390\/ijms20184647","article-title":"Interstitial flow recapitulates gemcitabine chemoresistance in a 3D microfluidic pancreatic ductal adenocarcinoma model by induction of multidrug resistance proteins","volume":"20","author":"Kramer","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0270","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1039\/D2BM00881E","article-title":"PDAC-on-chip for in vitro modeling of stromal and pancreatic cancer cell crosstalk","volume":"11","author":"Sgarminato","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioadv.2026.214984_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.actbio.2016.11.072","article-title":"Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer","volume":"49","author":"Brancato","year":"2017","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214984_bb0280","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jbiomech.2009.11.007","article-title":"Cells in 3D matrices under interstitial flow: effects of extracellular matrix alignment on cell shear stress and drag forces","volume":"43","author":"Pedersen","year":"2010","journal-title":"J. Biomech."},{"key":"10.1016\/j.bioadv.2026.214984_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2023.100158","article-title":"Fluid mechanics in circulating tumour cells: role in metastasis and treatment strategies","volume":"18","author":"Rajput","year":"2023","journal-title":"Medicine in Drug Discovery"},{"key":"10.1016\/j.bioadv.2026.214984_bb0290","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CMAR.S65444","article-title":"Interstitial fluid flow in cancer: implications for disease progression and treatment","volume":"6","author":"Munson","year":"2014","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.2012.569","article-title":"Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer","volume":"108","author":"Provenzano","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214984_bb0300","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1039\/D3LC00660C","article-title":"Modelling and breaking down the biophysical barriers to drug delivery in pancreatic cancer","volume":"24","author":"Kpeglo","year":"2024","journal-title":"Lab Chip"},{"key":"10.1016\/j.bioadv.2026.214984_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2022.111362","article-title":"Fluid-sensitive migration mechanisms predict association between metastasis and high interstitial fluid pressure in pancreatic cancer","volume":"145","author":"N\u00e6vdal","year":"2022","journal-title":"J. Biomech."},{"key":"10.1016\/j.bioadv.2026.214984_bb0320","series-title":"Cancer Cell Culture: Methods and Protocols","first-page":"221","article-title":"A step-by-step methodological guide for developing zonal multicellular scaffold-based pancreatic cancer models","author":"Gupta","year":"2023"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214984_bb0335","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2353\/ajpath.2009.090131","article-title":"Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, \u03b2-catenin, and ezrin expression in tumor cells","volume":"175","author":"Froeling","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214984_bb0340","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.22.01134","article-title":"Adjuvant nab-paclitaxel+ gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial","volume":"41","author":"Tempero","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioadv.2026.214984_bb0345","doi-asserted-by":"crossref","first-page":"S1323","DOI":"10.1016\/j.annonc.2023.10.084","article-title":"LBA83 neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): a multicenter randomized controlled trial","volume":"34","author":"Koerkamp","year":"2023","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214984_bb0350","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214984_bb0355","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ymthe.2022.11.004","article-title":"Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer","volume":"31","author":"Shi","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioadv.2026.214984_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837503","article-title":"Integrating gemcitabine-based therapy with adiporon enhances growth inhibition in human pdac cell lines","volume":"13","author":"Ragone","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.bioadv.2026.214984_bb0365","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-19-2959","article-title":"Long-term gemcitabine treatment reshapes the pancreatic tumor microenvironment and sensitizes murine carcinoma to combination immunotherapy","volume":"80","author":"Principe","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0370","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-016-2671-9","article-title":"NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice","volume":"16","author":"De Vita","year":"2016","journal-title":"BMC Cancer"},{"issue":"23","key":"10.1016\/j.bioadv.2026.214984_bb0375","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/cancers13236080","article-title":"On the evaluation of a novel hypoxic 3D pancreatic cancer model as a tool for radiotherapy treatment screening","volume":"13","author":"Wishart","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214984_bb0380","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1136\/gutjnl-2021-325180","article-title":"Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.bioadv.2026.214984_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240833","article-title":"Comparison of VEGF-A secretion from tumor cells under cellular stresses in conventional monolayer culture and microfluidic three-dimensional spheroid models","volume":"15","author":"Sarkar","year":"2020","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214984_bb0390","article-title":"Chemotherapy assessment in advanced multicellular 3D models of pancreatic cancer: unravelling the importance of spatiotemporal mimicry of the tumor microenvironment","volume":"8","author":"Gupta","year":"2024","journal-title":"Adv. Biol. (Weinh)"},{"issue":"6","key":"10.1016\/j.bioadv.2026.214984_bb0395","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","article-title":"The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214984_bb0400","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13058-021-01473-0","article-title":"Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells","volume":"23","author":"Fuh","year":"2021","journal-title":"Breast Cancer Res."},{"issue":"22","key":"10.1016\/j.bioadv.2026.214984_bb0410","doi-asserted-by":"crossref","first-page":"E1974","DOI":"10.1073\/pnas.1216989110","article-title":"Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules","volume":"110","author":"Rizvi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Suppl4","key":"10.1016\/j.bioadv.2026.214984_bb0415","doi-asserted-by":"crossref","first-page":"S597","DOI":"10.33549\/physiolres.934783","article-title":"Pancreatic stellate cells - rising stars in pancreatic pathologies","volume":"70","author":"Hrab\u00e1k","year":"2021","journal-title":"Physiol. Res."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214984_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70788","article-title":"Fibrotic fortresses and therapeutic frontiers: pancreatic stellate cells and the extracellular matrix in pancreatic cancer","volume":"14","author":"Sigirli","year":"2025","journal-title":"Cancer Med."},{"issue":"2021","key":"10.1016\/j.bioadv.2026.214984_bb0425","article-title":"Heterogeneous pancreatic stellate cells are powerful contributors to the malignant progression of pancreatic cancer","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0430","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214984_bb0435","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/mi13020305","article-title":"Fibroblast derived skin wound healing modeling on chip under the influence of micro-capillary shear stress","volume":"13","author":"Gupta","year":"2022","journal-title":"Micromachines"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0440","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/abd9d6","article-title":"Perfusion bioreactor enabled fluid-derived shear stress conditions for novel bone metastatic prostate cancer testbed","volume":"13","author":"Jasuja","year":"2021","journal-title":"Biofabrication"},{"key":"10.1016\/j.bioadv.2026.214984_bb0445","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.actbio.2022.03.044","article-title":"Microfluidic one-directional interstitial flow generation from cancer to cancer associated fibroblast","volume":"144","author":"Kim","year":"2022","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.bioadv.2026.214984_bb0450","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214984_bb0455","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.2010.226092","article-title":"Stromal biology and therapy in pancreatic cancer","volume":"60","author":"Neesse","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0460","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12885-021-07860-2","article-title":"Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Jiang","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0465","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/s10434-011-1836-7","article-title":"The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection","volume":"19","author":"Chen","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214984_bb0470","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.V94.6.2080","article-title":"Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin\u2019s lymphomas","volume":"94","author":"Kossakowska","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0475","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4049\/jimmunol.1301906","article-title":"IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages","volume":"192","author":"Kothari","year":"2014","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.bioadv.2026.214984_bb0480","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.3390\/molecules26237076","article-title":"Inhibition of interleukin-6-induced matrix metalloproteinase-2 expression and invasive ability of lemon peel polyphenol extract in human primary colon cancer cells","volume":"26","author":"Pagliara","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214984_bb0485","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3892\/ijo.2014.2323","article-title":"Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9","volume":"44","author":"Sun","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"16","key":"10.1016\/j.bioadv.2026.214984_bb0490","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1042\/CS20191211","article-title":"Emerging roles for the IL-6 family of cytokines in pancreatic cancer","volume":"134","author":"van Duijneveldt","year":"2020","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0495","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1007\/s13277-015-4186-4","article-title":"IL-6\/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients","volume":"37","author":"Zergoun","year":"2016","journal-title":"Tumour Biol."},{"issue":"11","key":"10.1016\/j.bioadv.2026.214984_bb0500","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1541-7786.MCR-16-0180","article-title":"Systemic ablation of MMP-9 triggers invasive growth and metastasis of pancreatic cancer via deregulation of IL6 expression in the bone marrow","volume":"14","author":"Gr\u00fcnwald","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214984_bb0505","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s10439-011-0309-2","article-title":"Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts","volume":"39","author":"Shi","year":"2011","journal-title":"Ann. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214984_bb0510","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10237-012-0385-8","article-title":"Effect of the glycocalyx layer on transmission of interstitial flow shear stress to embedded cells","volume":"12","author":"Tarbell","year":"2013","journal-title":"Biomech. Model. Mechanobiol."},{"issue":"17","key":"10.1016\/j.bioadv.2026.214984_bb0515","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/cells12172205","article-title":"Slow interstitial fluid flow activates TGF-\u03b2 signaling and drives fibrotic responses in human tenon fibroblasts","volume":"12","author":"Wiedenmann","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0520","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.bioadv.2026.214984_bb0525","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.3390\/cancers14163998","article-title":"The extracellular matrix: a key accomplice of cancer stem cell migration, metastasis formation, and drug resistance in PDAC","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioadv.2026.214984_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.621937","article-title":"The role of stellate cells in pancreatic ductal adenocarcinoma: targeting perspectives","volume":"10","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214984_bb0535","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/cancers13040601","article-title":"Stellate cells aid growth-permissive metabolic reprogramming and promote gemcitabine chemoresistance in pancreatic cancer","volume":"13","author":"Amrutkar","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214984_bb0540","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2016-311954","article-title":"Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer","volume":"67","author":"Hessmann","year":"2018","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214984_bb0545","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/cancers16081470","article-title":"Targeted therapy for highly desmoplastic and immunosuppressive tumor microenvironment of pancreatic ductal adenocarcinoma","volume":"16","author":"Olaoba","year":"2024","journal-title":"Cancers"},{"issue":"38","key":"10.1016\/j.bioadv.2026.214984_bb0550","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.18632\/oncotarget.27745","article-title":"Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy","volume":"11","author":"Ebelt","year":"2020","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214984_bb0555","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/cancers6042137","article-title":"Desmoplasia and chemoresistance in pancreatic cancer","volume":"6","author":"Schober","year":"2014","journal-title":"Cancers"},{"issue":"24","key":"10.1016\/j.bioadv.2026.214984_bb0560","doi-asserted-by":"crossref","first-page":"2104594","DOI":"10.1002\/advs.202104594","article-title":"Remediating desmoplasia with EGFR-targeted photoactivable multi-inhibitor liposomes doubles overall survival in pancreatic cancer","volume":"9","author":"Obaid","year":"2022","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214984_bb0565","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.7150\/thno.53102","article-title":"Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826002827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826002827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T21:42:20Z","timestamp":1786052540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826002827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":109,"alternative-id":["S2772950826002827"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214984","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the impact of dynamic fluid flow on an advanced model of pancreatic cancer: Towards desmoplasia disruption and chemosensitivity promotion","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214984"}}